Process View
Any process that stops, prevents, or reduces the frequency, rate, or extent of the production of molecular mediator of immune response.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of production of molecular mediator of immune response"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| LILRA6 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | 0.855 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.789 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.691 | ||
| ALB | albumin | 0.641 | ||
| PILRA | paired immunoglobin-like type 2 receptor alpha | 0.577 | ||
| HP | haptoglobin | 0.540 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.435 | Human | |
| CD14 | CD14 molecule | 0.339 | ||
| LILRB3 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 | 0.324 | Human | |
| APOC1 | apolipoprotein C-I | 0.286 | ||
| MYD88 | myeloid differentiation primary response gene (88) | 0.262 | ||
| LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 0.240 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.211 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.209 | ||
| IL22RA2 | interleukin 22 receptor, alpha 2 | 0.196 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.192 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.180 | Human | |
| LILRB2 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 | 0.119 | Human | |
| CCR4 | chemokine (C-C motif) receptor 4 | 0.098 | ||
| IRAK2 | interleukin-1 receptor-associated kinase 2 | 0.080 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.079 | Human | |
| CCL7 | chemokine (C-C motif) ligand 7 | 0.076 | Human | |
| IL8 | interleukin 8 | 0.074 | ||
| EPOR | erythropoietin receptor | 0.072 | ||
| IL22RA1 | interleukin 22 receptor, alpha 1 | 0.069 | ||
| LILRA1 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | 0.067 | Human | |
| TEK | TEK tyrosine kinase, endothelial | 0.067 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.067 | ||
| IL10 | interleukin 10 | 0.064 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.064 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.059 | ||
| IDE | insulin-degrading enzyme | 0.057 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.056 | Human | |
| IL1B | interleukin 1, beta | 0.056 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.054 | ||
| THOC5 | THO complex 5 | 0.052 | ||
| APOC3 | apolipoprotein C-III | 0.049 | ||
| HDAC9 | histone deacetylase 9 | 0.047 | ||
| SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.047 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.046 | ||
| THOC4 | THO complex 4 | 0.045 | ||
| LILRA3 | leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 | 0.044 | Human | |
| CCL22 | chemokine (C-C motif) ligand 22 | 0.043 | Human | |
| APOC2 | apolipoprotein C-II | 0.041 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.041 | Human | |
| APOA2 | apolipoprotein A-II | 0.039 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.039 | ||
| NLRP3 | NLR family, pyrin domain containing 3 | 0.038 | ||
| HK3 | hexokinase 3 (white cell) | 0.035 | ||
| IFNG | interferon, gamma | 0.035 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.034 | Human | |
| DDX39B | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B | 0.032 | ||
| LILRA2 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 | 0.032 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.031 | ||
| APOA1 | apolipoprotein A-I | 0.030 | ||
| THOC2 | THO complex 2 | 0.030 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.030 | ||
| NKG7 | natural killer cell group 7 sequence | 0.029 | ||
| FGA | fibrinogen alpha chain | 0.029 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.028 | ||
| TNF | tumor necrosis factor | 0.026 | ||
| ZNF830 | zinc finger protein 830 | 0.025 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.024 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.023 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.023 | ||
| ENG | endoglin | 0.023 | ||
| KRT15 | keratin 15 | 0.022 | ||
| FSTL1 | follistatin-like 1 | 0.022 | ||
| PCDH9 | protocadherin 9 | 0.022 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.022 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.022 | ||
| CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.021 | ||
| FRA10AC1 | fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1 | 0.021 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.021 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.020 | ||
| TREM1 | triggering receptor expressed on myeloid cells 1 | 0.019 | ||
| ZC3H12A | zinc finger CCCH-type containing 12A | 0.019 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.019 | Human | |
| PTAFR | platelet-activating factor receptor | 0.019 | ||
| EBI3 | Epstein-Barr virus induced 3 | 0.018 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.018 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.018 | ||
| ITGB1BP1 | integrin beta 1 binding protein 1 | 0.018 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.018 | ||
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.018 | Human | |
| AOAH | acyloxyacyl hydrolase (neutrophil) | 0.017 | ||
| FPR3 | formyl peptide receptor 3 | 0.017 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.017 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.016 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.015 | ||
| IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.015 | ||
| FCN1 | ficolin (collagen/fibrinogen domain containing) 1 | 0.015 | ||
| CH25H | cholesterol 25-hydroxylase | 0.015 | ||
| MARCO | macrophage receptor with collagenous structure | 0.014 | ||
| BCL2A1 | BCL2-related protein A1 | 0.014 | ||
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.014 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.014 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.014 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.014 | Human | |
| LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.014 | ||
| SIRPB1 | signal-regulatory protein beta 1 | 0.013 | ||
| IL2RA | interleukin 2 receptor, alpha | 0.013 | ||
| FCGR2C | Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) | 0.013 | ||
| ANGPT2 | angiopoietin 2 | 0.013 | ||
| CCL23 | chemokine (C-C motif) ligand 23 | 0.012 | Human | |
| LILRB4 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 | 0.011 | Human | |
| IRF4 | interferon regulatory factor 4 | 0.011 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.011 | ||
| IKZF3 | IKAROS family zinc finger 3 (Aiolos) | 0.011 | ||
| SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 0.011 | ||
| KCNQ1 | potassium voltage-gated channel, KQT-like subfamily, member 1 | 0.011 | ||
| CD83 | CD83 molecule | 0.011 | ||
| FPR2 | formyl peptide receptor 2 | 0.010 |